INCOME TAXES - Research and Development Tax Credits (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Jan. 31, 2025 |
Jan. 31, 2024 |
Jan. 31, 2023 |
Jan. 31, 2026 |
|
| INCOME TAXES | ||||
| Federal research and development tax credits | $ 5.8 | |||
| Development tax credit | $ 2.4 | |||
| Deferred Tax Assets, Operating Loss Carryforwards, Foreign | $ 13.7 | |||
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | $ 1.4 | $ 2.1 | ||
| X | ||||||||||
- Definition Amount of decrease in unrecognized tax benefits resulting from research and development tax credit. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|